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Summary
 
In Leishmaniasis, as in many infectious diseases, clinical manifestations are determined by the
interaction between the genetics of the host and of the parasite. Here we describe studies map-
ping two loci controlling resistance to murine cutaneous leishmaniasis. Mice infected with
 
L. major
 
 show marked genetic differences in disease manifestations: BALB/c mice are suscepti-
ble, exhibiting enlarging lesions that progress to systemic disease and death, whereas C57BL/6
are resistant, developing small, self-healing lesions. F2 animals from a C57BL/6 
 
3
 
 BALB/c
cross showed a continuous distribution of lesion score. Quantitative trait loci (QTL) have been
mapped after a non-parametric QTL analysis on a genome-wide scan on 199 animals. QTLs
identified were confirmed in a second cross of 271 animals. Linkage was confirmed to a chro-
mosome 9 locus (D9Mit67–D9Mit71) and to a region including the H2 locus on chromosome
17. These have been named 
 
lmr2
 
 and 
 
lmr1
 
, respectively.
 
S
 
uccessful resolution of an infectious disease requires precise
control of the delicate immunologic balance between
eradication of the invading organism and self harm. The
genetic interplay between microorganism and host deter-
mines the disease outcome, notably the elimination of mi-
crobes and associated immunopathologies. Leishmaniasis is
an excellent example of a complex parasite–host interaction.
Different 
 
Leishmania
 
 species cause clinically distinct diseases
and the severity of disease caused by any given parasite can
vary markedly between individual hosts (1, 2). This obser-
vation extends to the murine 
 
L. major
 
 model where the
strain of inbred mouse determines the outcome of infec-
tion, C57BL/6 mice being uniformly resistant and BALB/c
consistently susceptible (3).
While the genetic basis for resistance to parasitic infec-
tions is largely unknown, indirect evidence suggests that the
induction of distinct CD4
 
1
 
 T cell responses modulates out-
come and pathology (4). In leishmaniasis, resistant C57BL/6
mice infected with 
 
L. major
 
 produce an early CD4
 
1
 
 Th1
response (5). This results in IFN-
 
g
 
 production, macrophage
activation, parasite killing and resolution of the lesion (re-
viewed in reference 6). In contrast, susceptible BALB/c
mice mount an early Th2 response and progressive dissem-
inating disease ensues (5, 7). As the CD4
 
1
 
 T cell responses
in BALB/c and C57BL/6 mice mirror their clinical course, it
is tempting to speculate that genes regulating disease outcome
may be involved in the early control of T helper response
selection. Alternatively, it is possible that this response is
merely reflective of some more fundamental phenomenon
and that the genetic events underlying resistance to disease
control some other process. By studying disease outcome
in terms of clinical phenotype, assumptions of underlying
mechanisms are avoided. These are more easily addressed
once the genetics of resistance are understood. With this in
mind, we have undertaken to map loci involved in resis-
tance to 
 
L. major
 
 infection using large F2 intercrosses be-
tween C57BL/6 and BALB/c mice.
Genetic approaches to mapping murine responses to 
 
L. ma-
jor
 
, although previously reported, have been inconclusive.
Recombinant inbred (RI) lines have been used to map a
trait which, despite claims to the contrary (8), is obviously
complex. These RI lines do not represent sufficient mei-
oses for accurate or reliable mapping of a multigenic trait.
Nevertheless, a disease response locus has been mapped to
chromosome 11 (
 
Scl1)
 
 (9). In a separate experiment, not
involving 
 
L. major
 
 infection but rather in vitro responsive-
ness of CD4
 
1
 
 
 
cells to IL-12, linkage was found to the same
chromosome (10). While linking this locus to resistance to
 
L. major
 
 is seductive, because it contains a host of conceiv-
ably relevant cytokines and their receptors, no definitive
genetic study has been published (11). We present pheno-
type and genotype data from 470 F2 animals that demon-
strate the complex genetic and environmental nature of
resistance to 
 
L. major
 
, and describe linkage to two chromo-
somal regions: one on chromosome 9 and the other at the
H2 locus on chromosome 17.
 
Materials and Methods
 
Mice.
 
All mice were bred and maintained in a specific patho-
gen-free environment at The Walter and Eliza Hall Institute of
Medical Research. The BALB/cAnBradleyWEHI and C57BL/6J
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strains were tested for genetic authenticity in July 1996. Two sep-
arate crosses were bred and independently challenged with 
 
L. ma-
jor 
 
parasites at 5 wk of age. Experiment A consisted of 12 parental
mice of each inbred strain (C57BL/6 and BALB/c), 24 F1 (pa-
rental cross), and 199 F2 (F1 intercross) mice. Experiment B
comprised six C57BL/6, 16 BALB/c, 12 F1, and 271 F2 mice.
Equal numbers of male and female F1 and F2 mice were used. F1
animals were generated from both BALB/c 
 
3
 
 C57BL/6 and
C57BL/6 
 
3
 
 BALB/c crosses and the F2 generation produced by
intercrossing within each of these F1 groups.
 
Infection.
 
In Experiment A, each mouse was infected intra-
dermally with 10
 
5 
 
viable 
 
L. major
 
 V121 promastigotes at the base
of the tail (12). The course of the infection was monitored
weekly for 5 1/2 mo using the scoring system described previ-
ously (13). Individual scores describe the size of the lesion, 0 rep-
resenting no lesion and 4 representing a lesion greater than 10
mm in diameter. A resistance score was assigned to individual
mice by taking the average of its lesion scores between weeks 3
and 14. Animals with large progressive lesions and incipient sys-
temic involvement were killed to minimize suffering. Weeks 1
and 2 were excluded because of the difficulty discriminating be-
tween a developing lesion and a healing injection site. For Exper-
iment B, the parasites used were less virulent than for Experiment
A. Therefore, 2 
 
3
 
 10
 
5
 
 promastigotes were inoculated. Lesions
were scored weekly for 14 wk.
 
The Parasite.
 
The 
 
L. major
 
 cloned line V121 was originally
obtained from a patient with cutaneous leishmaniasis in Israel,
and stabilates have been maintained in liquid nitrogen with peri-
odic passage through nude mice. For infection of mice, the para-
sites were cultured in the biphasic blood agar medium NNN
(14). A parasite clone of diminished virulence was used in these
experiments and parasite inoculum was titrated against disease
outcome. The parasite dose chosen ensures that resistance in the
C57BL/6 mice is completely penetrant, however, a percentage of
BALB/c mice were not totally susceptible. The use of a parasite
of lower virulence allows more certainty when mapping loci in
susceptible F2 animals.
 
Genotyping.
 
Genomic DNA was prepared from tail snips
from each F2 mouse (15). DNA from all F2 animals from Exper-
iment A were individually screened by PCR (16) against 126
simple sequence length polymorphic (SSLP) markers (17) chosen
from the Whitehead Institute collection (18). This represents an
average 12 cM density of markers across the genome. Genotyping
was performed using an adaptation of the multiplex sequencing
method of Church and Richterich (19, 20). Multiple PCR prod-
ucts were pooled, ethanol precipitated and loaded onto a 7% de-
naturing polyacrylamide gel. DNA was transferred onto nylon fil-
ters (Boehringer Mannheim, Mannheim, Germany) fixed by UV
light, and probed with biotinylated streptavidin alkaline–phos-
phatase conjugated oligonucleotides. The oligonucleotide probes
were one of the pair used in the initial PCR assays. Bands were
visualized by chemiluminescent autoradiography after washing and
incubation in the alkaline phosphatase substrate CDP-Star (Boeh-
ringer Mannheim). Filters were probed multiple times and assays
loaded so that several loci, differing in their allele size distribution
could be seen simultaneously. Three regions identified as sugges-
tive of linkage during the genome scan on the first 199 F2 animals
in Experiment A were tested for linkage with 11 SSLP markers in
the second 271 F2 animals (Experiment B).
 
Linkage Analysis.
 
Non-parametric quantitative trait locus (QTL)
linkage analysis was performed using the MAPMAKER package:
MAPMAKER/EXP 3.0B (21) and MAPMAKER/QTL 1.9 (ob-
tained from M. Daly, mjdaly@genome.mit.edu) on all 199 F2
animals from Experiment A. Since the trait does not follow a nor-
mal distribution, the non-parametric statistic, X
 
w
 
,
 
 
 
was used. The
ability of this test to account simultaneously for additive or domi-
nance effects of the trait at a locus without significantly compro-
mising its sensitivity to detect linkage makes it ideal for non-para-
metric genome scans (22). X
 
w 
 
values of 4.4 and above represent
increasingly significant evidence for linkage and are equivalent to
lod scores of 3.3 and above. Candidate regions identified from
Experiment A were genotyped in the 271 F2 animals from Ex-
periment B and linkage to candidate QTLs assessed using the
non-parametric X
 
w
 
 statistic in MAPMAKER/QTL 1.9.
To address the issue of decreased penetrance for susceptibility
(not all BALB/c mice were susceptible) a second linkage strategy
was employed. The hypothesis that the most susceptible animals
will be homozygous BALB/c at resistance loci was tested using a
 
x
 
2 
 
analysis. This was performed in all animals exhibiting a lesion
score of 4 by week 14 (9% of F2s), and departure from the ex-
pected 25% of homozygous BALB/c genotypes and 75% of non-
homozygous BALB/c genotypes was calculated. Linkage to the
candidate loci was then determined using a binomial model (23).
A lod score of 3.3 or greater indicates strong support for linkage.
 
Results
 
Disease Phenotype.
 
The pattern of disease after infection
with 
 
L. major
 
 was similar in the two experiments (Figs. 1
and 2). The disease in the isogenic parental and F1 groups
was as anticipated: BALB/c mice rapidly progressed to dis-
seminated disease, F1 mice were intermediate in their resis-
tance and C57BL/6 mice were uniformly resistant. All
groups in the second experiment were slightly more resis-
tant than the groups in the first experiment.
Resistance in the F2 generation was a continuum spread
between the two parental extremes (Fig. 2). 25% of all F2
animals developed no lesion and only 9% of animals reca-
pitulated the susceptible, BALB/c-like phenotype. The dis-
tribution was not normal, being skewed towards resistance.
A novel intermediate phenotype was observed where le-
sions, which developed to a moderate size, persisted with-
out progression or cure. After 23 wk, 12% of mice dis-
Figure 1. The kinetics of lesion development after L. major infection in
BALB/c, C57BL/6, and their F1 generation expressed as the median le-
sion score over time. A shows results from 12 BALB/c, 12 C57BL/6, and
24 F1 mice. B shows the second experiment with 16 BALB/c, 6 C57BL/6,
and 12 F1 mice. The vertical bars represent the semi-interquartile ranges.
As all C57BL/6 mice cure their lesions, resistance is fully penetrant. 
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played this undifferentiated phenotype. The outcome at 23
wk was retrospectively predictable at 14 wk after inocula-
tion.
 
Genetic Linkage.
 
MAPMAKER/EXP 3.0B was used to
build a genetic map from the genotypic data. This map or-
der agreed with published marker order and distances (18).
A QTL scan of the genome was performed using a non-
parametric method as implemented in MAPMAKER/
QTL 1.9 (Fig. 3). A single region showing significant link-
age was observed overlying the proximal end of chromo-
some 17 (X
 
w 
 
value 
 
5
 
 5.3). Two further regions suggestive
of linkage were detected on chromosomes 9 (X
 
w
 
 
 
5
 
 3.4)
and 15 (X
 
w
 
 
 
5
 
 3.3). Markers from these regions were used
to confirm linkage with the second set of 271 animals. The
chromosome 9 and 17 results were sustained, whereas link-
age was not confirmed for the chromosome 15 locus. The
support for linkage from the two combined experiments
was X
 
w
 
 
 
5
 
 4.4 for the chromosome 9 locus with the peak
between D9Mit67 and D9Mit71, and X
 
w
 
 
 
5
 
 7.1 for the
chromosome 17 locus, the peak being found between
D17Mit11 and D17Mit115. The locus on chromosome 9
has been called 
 
lmr2
 
, and the chromosome 17 locus, 
 
lmr1
 
.
Susceptibility showed incomplete penetrance in the pa-
rental BALB/c animals whereas resistance was fully pene-
trant in the parental C57BL/6 mice, a situation likely to be
reiterated in the F2 animals. Therefore, a 
 
x
 
2 
 
analysis was
performed on all susceptible animals (defined as those ani-
mals with a lesion score of 4 by week 14). A dominance
model for resistance was assumed and loci implicated by
the non-parametric scan were studied. The homozygous
BALB/c genotype was significantly skewed toward suscep-
tibility at the chromosome 9 and 17 locus (Tables 1 and 2).
Lod scores were then calculated using a binomial model
that revealed evidence for significant linkage for markers on
chromosome 17 (lod 
 
5 
 
7.2) and chromosome 9 (lod 
 
5 
 
3.7).
No segregation distortion is evident at these regions (Table 2).
Given the previous literature linking resistance to chromo-
some 11, lod scores were calculated for all chromosome 11
markers for all of the 199 animals in Experiment A. The
highest lod score obtained was 0.323 for D11Mit208 and lod
scores for markers surrounding the putative gene encoding
resistance were 
 
2
 
0.01 (D11Mit212), 0.159 (D11Mit59),
and 0.002 (D11Mit202).
 
Discussion
 
Gene mapping of 470 F2 mice infected with 
 
L. major
 
parasites led to the identification of two host loci control-
ling disease outcome. The phenotype was limited to the
clinical outcome after promastigote infection at the base of
the tail. No immunological or parasitological correlates of
disease were studied. These would have interfered with the
study of outcome and will be studied upon production of
congenic mice. The strain of parasite and infection dose
were chosen to optimize the measurement of susceptibility
by ensuring that the major determinant of susceptibility
was genetic. This resulted in a percentage of the BALB/c
mice showing variable severity of disease indicating the ac-
tion of either environmental or stochastic influences, an
Figure 2. The kinetics of lesion development after L. major infection in
the F2 generation expressed as the lesion score over time. A and B repre-
sent two separate experiments with 199 and 271 F2 mice, respectively.
The first quartile represents the lesion score of the animal at the 25th per-
centile, the second quartile represents the 50th percentile animal, etc.
These data demonstrate a continuous distribution of this trait in the F2
generation. Animals were slightly more resistant in the second experiment
compared to the first.
Figure 3. A 12 cM density genome-wide non-parametric QTL scan
for outcome of L. major infection in 199 F2 mice. The results are ex-
pressed as the non-parametric Xw score. Linkage is considered significant
at the threshold of 4.4, which is equivalent to a lod score of 3.3. Chr. 5
Chromosome.
 
Table 1.
 
Linkage of Susceptibility to Chromosomes 17 and 9
 
Marker Position
 
x
 
2
 
p value Lod score
 
*
 
cM
 
D17Mit11 11 36 1.8 
 
3
 
 10
 
2
 
9
 
6.6
D17Mit115 19 40 2.9 
 
3
 
 10
 
2
 
10
 
7.2
D17Mit66 25 30 2.1 
 
3
 
 10
 
2
 
8
 
5.8
D9Mit67 17 16 2.7 
 
3
 
 10
 
2
 
5
 
3.3
D9Mit71 29 19 5.4 
 
3
 
 10
 
2
 
6
 
3.7
D9Mit133 43 0.24 0.53 0.085
 
x
 
2
 
 analysis and lod scores for linkage of susceptibility to markers sur-
rounding the two QTLs in the most susceptible mice.
 
*
 
Lod scores were calculated using a binomial model. Scores of 3.3 and
greater indicate significant linkage. 
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observation not unique to this study (24). Inter- and intra-
experimental phenotypic variation was small, parental ani-
mals being either entirely resistant (C57BL/6) or largely
susceptible (BALB/c), and the F2 progeny falling along a
continuous distribution as expected of a quantitative trait.
F1 animals were less resistant than the C57BL/6 mice. They
do, however, cure their lesions indicating that susceptibility
is a recessive trait.
Three loci were identified on an initial genome-wide scan
performed on 199 F2 mice. Significant linkage was found
for the peak on chromosome 17 (D17Mit11–D17Mit115),
but the two other peaks on chromosomes 9 (D9Mit67–
D9Mit71) and 15 (D15Mit58–D15Mit159) were only sug-
gestive of linkage. Therefore, markers surrounding all three
loci were tested on a second set of 271 animals. Linkage
was confirmed for chromosomes 9 and 17 but not for the
chromosome 15 locus. These findings were validated using
a simple approach that linked susceptibility to markers sur-
rounding the chromosomes 9 and 17 loci in only those
most susceptible of animals. This test was possible due to
the choice of a lower virulent parasite giving rise to a sus-
ceptibility phenotype in which virtually all phenotypic
control is genetic.
At least two genes control the host response to 
 
L. major
 
in a cross between BALB/c and C57BL/6. While linkage
to chromosome 17 was significant in the initial 199 ani-
mals, the chromosome 9 locus required the full 940 mei-
oses before the genome-wide significance threshold was
reached. It is quite possible that other genes are involved in
this cross and were not detected in the linkage analysis.
This is in part inferred from the fact that not all the suscep-
tible animals are homozygous for either the chromosome 9
or 17 loci (data not shown), indicating the activity of other
genetic or environmental factors. Given that two genes
have been identified in a cross representing the genetic di-
versity of only one outbred individual, it is likely that other
naturally occurring polymorphisms will also influence out-
come of 
 
L. major
 
 infection. These may be identified in
other crosses and may explain the discordancies with previ-
ous mapping efforts (9, 24).
Although it is still early to speculate about candidate
genes, it has not escaped our notice that the H2 locus lies
directly beneath the peak of the QTL scan on chromosome
17. The role of H2 in resistance to 
 
L. major
 
 is far from
clear. Studies using mice congenic for the H2 locus have
shown no effect
 
 
 
or little effect (8, 3). The small effect dem-
onstrated by Howard et al. was a slowing of the rate of le-
sion expansion in BALB/K animals. A similar, but more
pronounced effect was seen in BALB/c.H-2
 
k 
 
animals where
lesions healed (25). However, these were different congenic
animals from those of Howard et al. Explanations for the
discordant results may lie in the different mouse strains used
for the experiments, the different origins of the H2 regions
in the congenic mice, the number of generations of back-
crossing, or the different size of the remaining donor region
flanking H2 in the congenic mice. These issues may be re-
solved once fine mapping of the chromosome 17 region is
completed and the precise location of 
 
lmr1
 
 is determined.
For completeness, the chromosome 9 locus overlies the IL-10
receptor, which makes it an attractive candidate consider-
ing the role of IL-10 in 
 
L. major
 
 infection (26).
Although no immunological measurements were made in
these animals, there is abundant evidence that the CD4
 
1
 
lymphocyte response is crucial in controlling the outcome
of 
 
L. major
 
 infection. Therefore, it is possible that one or
both loci described in this work contribute to the early es-
tablishment of this response. This matter will be more eas-
ily investigated in animals made congenic at these loci.
Mouse strain differences in terms of in vitro T helper cell
responses have been mapped in the mouse to chromosome
11 (10), a chromosome to which 
 
L. major 
 
resistance has also
been mapped (9, 24). Mock et al. used animals from seven
RI lines generated from a C57BL/6 
 
3
 
 BALB/c cross to
map resistance to this region. Although they used too few
animals to generate statistically significant linkage, their data
are, in fact, also consistent with mapping to the H2 region.
 
Table 2.
 
Relationship of Genotype to Susceptibility at Linked Markers
 
Marker Position
4th quartile 3rd quartile 2nd quartile 1st quartile
c/c b/b b/c c/c b/b b/c c/c b/b b/c c/c b/b b/c
cM
D17Mit11 11 54 13 37 18 29 58 15 27 50 17 37 50
D17Mit115 19 52 13 39 19 28 60 19 23 49 16 39 49
D17Mit66 25 55 17 39 25 29 59 25 28 55 18 40 53
D9Mit67 17 46 20 46 26 34 51 31 25 54 21 28 65
D9Mit71 29 44 22 44 26 31 54 29 19 66 21 27 61
D9Mit133 43 31 32 49 26 40 44 32 24 54 19 40 51
Genotypes of F2 mice split into quartiles based on decreasing susceptibility score. Genotype b/b represents a mouse homozygous for C57BL/6 alleles,
c/c homozygous for BALB/c, and b/c heterozygotes.1709 Roberts et al. Brief Definitive Report
We find no linkage to any region of chromosome 11, im-
plying that the locus mediating CD41 lymphocyte response
in the in vitro model reported by Gorham et al. (10) has no
measurable effect on the progression of L. major–induced
disease in our C57BL/6 3 BALB/c cross. This may reflect
the different phenotypes used and if so, it follows that the
phenotype measured by Gorham et al. acts independently
to outcome in L. major infection (10).
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